| Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy M Volante, MP Brizzi, A Faggiano, S La Rosa, I Rapa, A Ferrero, ... Modern Pathology 20 (11), 1172-1182, 2007 | 335 | 2007 |
| Grading the neuroendocrine tumors of the lung: an evidence-based proposal G Rindi, C Klersy, F Inzani, G Fellegara, L Ampollini, A Ardizzoni, ... Endocrine-related cancer 21 (1), 1-16, 2014 | 239 | 2014 |
| Expression of the neuroendocrine phenotype in carcinomas of the breast. A Sapino, L Righi, P Cassoni, M Papotti, F Pietribiasi, G Bussolati Seminars in diagnostic pathology 17 (2), 127-137, 2000 | 200 | 2000 |
| Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with … L Righi, MG Papotti, P Ceppi, A Billè, E Bacillo, L Molinaro, E Ruffini, ... J Clin Oncol 28 (9), 1534-1539, 2010 | 195 | 2010 |
| Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 ‘clinically aggressive’cases L Righi, M Volante, V Tavaglione, A Billè, L Daniele, T Angusti, F Inzani, ... Annals of Oncology 21 (3), 548-555, 2010 | 190 | 2010 |
| Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study ML Iacono, V Monica, L Righi, F Grosso, R Libener, S Vatrano, P Bironzo, ... Journal of thoracic oncology 10 (3), 492-499, 2015 | 176 | 2015 |
| Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology: a retrospective study of 103 cases with surgical correlation L Righi, P Graziano, A Fornari, G Rossi, M Barbareschi, A Cavazza, ... Cancer 117 (15), 3416-3423, 2011 | 174 | 2011 |
| Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women A Sapino, L Righi, P Cassoni, M Papotti, P Gugliotta, G Bussolati Modern Pathology 14 (8), 768-776, 2001 | 171 | 2001 |
| Classification of pulmonary neuroendocrine tumors: new insights G Pelosi, A Sonzogni, S Harari, A Albini, E Bresaola, C Marchiò, F Massa, ... Translational lung cancer research 6 (5), 513, 2017 | 140 | 2017 |
| Neuroendocrine differentiation in breast cancer: established facts and unresolved problems L Righi, A Sapino, C Marchio, M Papotti, G Bussolati Seminars in diagnostic pathology 27 (1), 69-76, 2010 | 137 | 2010 |
| BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study L Righi, E Duregon, S Vatrano, S Izzo, J Giorcelli, M Rondón-Lagos, ... Journal of Thoracic Oncology 11 (11), 2006-2017, 2016 | 116 | 2016 |
| Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum S Deaglio, A Capobianco, A Calı, F Bellora, F Alberti, L Righi, A Sapino, ... Blood, The Journal of the American Society of Hematology 100 (10), 3782-3789, 2002 | 112 | 2002 |
| Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors P Ceppi, M Volante, A Ferrero, L Righi, I Rapa, R Rosas, A Berruti, ... Clinical cancer research 14 (4), 1059-1064, 2008 | 107 | 2008 |
| Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung V Monica, P Ceppi, L Righi, V Tavaglione, M Volante, G Pelosi, ... Modern Pathology 22 (5), 709-717, 2009 | 106 | 2009 |
| Multicenter comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) assays to test PD-L1 expression for NSCLC patients to be treated with immune checkpoint inhibitors A Marchetti, M Barberis, R Franco, G De Luca, MV Pace, S Staibano, ... Journal of Thoracic Oncology 12 (11), 1654-1663, 2017 | 105 | 2017 |
| Clinical significance of neuroendocrine carcinoma of the breast A Sapino, M Papotti, L Righi, P Cassoni, L Chiusa, G Bussolati Annals of oncology 12, S115-S117, 2001 | 103 | 2001 |
| Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung L Righi, M Volante, I Rapa, V Tavaglione, F Inzani, G Pelosi, M Papotti Endocrine-related cancer 17 (4), 977-987, 2010 | 99 | 2010 |
| Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma M Betti, E Casalone, D Ferrante, A Aspesi, G Morleo, A Biasi, M Sculco, ... Cancer letters 405, 38-45, 2017 | 91 | 2017 |
| Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer L Daniele, P Cassoni, E Bacillo, S Cappia, L Righi, M Volante, F Tondat, ... Journal of Thoracic Oncology 4 (6), 684-688, 2009 | 91 | 2009 |
| Role of surgical resection in colorectal lung metastases: analysis of 137 patients P Borasio, M Gisabella, A Billé, L Righi, M Longo, M Tampellini, ... International journal of colorectal disease 26, 183-190, 2011 | 90 | 2011 |
paola cassoniUniversità di torinoEmail verificata su unito.it
